792 related articles for article (PubMed ID: 18780622)
21. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].
Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H
Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
23. [A case of occult breast carcinoma with irradiation therapy and axillary lymph node dissection].
Sugiyama Y; Morifuji M; Tatsumoto N; Sasaki M; Naito H; Kai Y
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1287-9. PubMed ID: 16969026
[TBL] [Abstract][Full Text] [Related]
24. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node?
Guth AA; Mercado C; Roses DF; Hiotis K; Skinner K; Diflo T; Cangiarella J
Am J Surg; 2006 Oct; 192(4):502-5. PubMed ID: 16978960
[TBL] [Abstract][Full Text] [Related]
25. Axillary metastasis from occult breast carcinoma: diagnosis and management.
Jackson B; Scott-Conner C; Moulder J
Am Surg; 1995 May; 61(5):431-4. PubMed ID: 7733550
[TBL] [Abstract][Full Text] [Related]
26. Bilateral axillary metastases of occult breast carcinoma: report of a case with a review of the literature.
Steunebrink M; Schnater JM; Storm RK; van Ingen G; Vegt PA; Plaisier PW
Breast; 2005 Apr; 14(2):165-8. PubMed ID: 15767189
[TBL] [Abstract][Full Text] [Related]
27. A patient with occult breast cancer presenting with an axillary lymph node metastasis and a synchronous contralateral breast cancer.
Yirmibeşoğlu E; Tekin E; Memiş L; Yamaç D; Taneri F; Erkal HS
Breast; 2005 Apr; 14(2):157-62. PubMed ID: 15767187
[TBL] [Abstract][Full Text] [Related]
28. Clinical importance of preoperative detection of the apical lymph node metastasis in patients with breast carcinoma.
Güven HE; Bulak H; Turanli S; Oral S
Singapore Med J; 2007 Jan; 48(1):31-3. PubMed ID: 17245513
[TBL] [Abstract][Full Text] [Related]
29. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
[TBL] [Abstract][Full Text] [Related]
30. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
Laura S; Coombs NJ; Ung O; Boyages J
ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of seven patients with occult breast cancer and literature reviews].
Yu H; Yang MT; Rong TH; Long H; Ou W
Ai Zheng; 2002 May; 21(5):541-3. PubMed ID: 12452050
[TBL] [Abstract][Full Text] [Related]
32. Heterotopic breast tissue versus occult metastatic carcinoma in lymph node, a diagnostic dilemma.
Ohsie SJ; Moatamed NA; Chang HR; Apple SK
Ann Diagn Pathol; 2010 Aug; 14(4):260-3. PubMed ID: 20637431
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography in diagnosis of occult adenocarcinoma of the breast.
Block EF; Meyer MA
Am Surg; 1998 Sep; 64(9):906-8. PubMed ID: 9731824
[TBL] [Abstract][Full Text] [Related]
34. Axillary metastatic disease as presentation of occult or contralateral breast cancer.
Lanitis S; Behranwala KA; Al-Mufti R; Hadjiminas D
Breast; 2009 Aug; 18(4):225-7. PubMed ID: 19656680
[TBL] [Abstract][Full Text] [Related]
35. Axillary staging in women with small invasive breast tumours.
della Rovere GQ; Bonomi R; Ashley S; Benson JR
Eur J Surg Oncol; 2006 Sep; 32(7):733-7. PubMed ID: 16814511
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis and treatment of occult breast cancer in 44 cases].
Lu S; Liu H
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):550-2. PubMed ID: 22093638
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
[TBL] [Abstract][Full Text] [Related]
38. Node-related factors and survival in node-positive breast carcinomas.
Sivridis E; Giatromanolaki A; Galazios G; Koukourakis MI
Breast; 2006 Jun; 15(3):382-9. PubMed ID: 16135406
[TBL] [Abstract][Full Text] [Related]
39. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy.
Atahan IL; Ozyigit G; Yildiz F; Gurkaynak M; Selek U; Sari S; Hayran M
Breast J; 2008; 14(3):245-9. PubMed ID: 18433402
[TBL] [Abstract][Full Text] [Related]
40. [Occult breast cancer].
Vasile D; Palade R; Voiculescu D
Chirurgia (Bucur); 1998; 93(4):247-53. PubMed ID: 9755574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
